Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Biotechnology_Biomarkers

Ezose Sciences Inc

Attachments

*Architects: Biotechnology_ Glycomics - Sugars
*Architects: Biotechnology_Biomarkers
*Architects: Diabetes, Metabolic Disease, Dialysis, Renal & Kidney Companies (Pharmaceuticals, Biotechnology, Biosimilars)
*Industry: New Jersey
Companies: Acquired_(M&A)
Shionogi Pharma (OTCPK:SGIOY)

2011: Ezose in agreement with Merck to Advance Glycan Biomarker Discovery in Diabetes (2011)
2011: Ezose Sciences Integrated into Shionogi Diagnostic Business
Has entered an agreement with Merck to collaborate on biomarker discovery research in the field of diabetes.
Pine Brook, New Jersey
Technology born at leading academic glycomics research team at Japan’s Hokkaido University.
Technology subsequently developed thru collaboration between Japanese companies: Shionogi & Co., Ltd. and Sumitomo Bakelite Co., Ltd.
The collaboration seeks to identify glycans, the complex carbohydrate component of glycoproteins, which can play a role in health and disease.
Unique high-throughput glycan analysis platform, combines several proprietary technologies to yield rapid and reproducible qualitative and quantitative results..